ScienceDex / Researcher record
Goundappa, Balasubramani K
- University of Pittsburgh · Public Health (NIH department code)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $2,657,465 | 1 | #2,117 |
| 2022 | $2,679,188 | 1 | #2,166 |
| 2023 | $2,769,231 | 1 | #2,133 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2021 · selected1 record
- FY20221 record
- FY20231 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Public Health
FY2021 award records by amount
NIH award records listing Goundappa, Balasubramani K as a PI. Multi-PI records show the full award amount for context.
- 5UG1EY031651-02UG1Contact PIClarifying the Optimal Application of SLT Therapy (COAST) TrialUniversity of Pittsburgh · Public Health (NIH department code)$2.7Maward amount
Award organization
Organizations that administered FY2021 awards listing Goundappa, Balasubramani K as a PI.
FY2021 award administered by University of Pittsburgh (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardUniversity of Pittsburgh
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #2117
- 2021Entered Top 25% NationallyRanked #2117
- 2022$5M Cumulative Funding